Arbutus Biopharma Corp
Pharmaceutical company · Warminster, Pennsylvania, United States · Nasdaq: ABUS
Arbutus Biopharma Corp is a pharmaceutical company headquartered in Warminster, Pennsylvania, United States. Its earliest recorded incorporation is in 2005. Its shares trade on Nasdaq under the ticker ABUS. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2021.
Arbutus Biopharma at a glance
What does Arbutus Biopharma do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $15 million sold (2021).
Frequently asked questions about Arbutus Biopharma
Where is Arbutus Biopharma headquartered?
Arbutus Biopharma Corp is headquartered in Warminster, Pennsylvania, United States.
What does Arbutus Biopharma do?
Arbutus Biopharma Corp is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Arbutus Biopharma a public company?
Yes. Arbutus Biopharma Corp trades on Nasdaq under the ticker ABUS.
When was Arbutus Biopharma founded?
The earliest incorporation on record for Arbutus Biopharma Corp is in 2005, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.